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Pyogenic liver abscess has become a health problem 
in Taiwanese society. However, the extent of this problem 
has remained unclear because of the lack of a population-
based study. We therefore performed a nationwide analysis 
of pyogenic liver abscess in Taiwan from 1996 through 2004. 
We analyzed 29,703 cases from the Taiwan National Health 
Insurance database and 506 cases from National Taiwan 
University Hospital. Our analysis showed that the annual 
incidence of pyogenic liver abscess increased steadily from 
11.15/100,000 population in 1996 to 17.59/100,000 in 2004. 
Diabetes, malignancy, renal disease, and pneumonia were 
associated with a higher risk for the disease. By contrast, 
death due to pyogenic liver abscess decreased over time, 
although population-based abscess-related death increased 
slightly. Renal disease, malignancy, pneumonia, and heart 
disease correlated with higher death rates; Klebsiella pneu-
moniae infection and therapeutic procedures were related 
to lower death rates. Diabetes did not signiﬁ  cantly change 
death rates for the 506 patients from the hospital. 
T
he epidemiology of pyogenic liver abscess has changed 
dramatically in recent years (1). Previously, although 
incidence was considered rare, the condition was associ-
ated with high illness and death rates, usually due to un-
derlying hepatobiliary diseases and polymicrobial infec-
tion (2), with Escherichia coli as the major pathogen (3). 
More recently, investigations in Taiwan suggest the role 
of cryptogenic or primary liver abscess, i.e., abscesses 
without underlying hepatobiliary diseases, in pyogenic 
liver abscess (4,5). These reports also indicate that diabetes 
is the major predisposing factor of liver abscess and that 
Klebsiella pneumoniae is the primary pathogen. However, 
these results were obtained from small-scale hospital-based 
surveys, which could not provide a panoramic view of the 
disease. To conﬁ  rm these observation-based results, we 
conducted a large-scale, unbiased investigation.
In addition to epidemiology, the pathogenesis of liver 
abscess caused by Klebsiella spp. has also been extensively 
studied, but the mechanism is still not clear. MagA, an outer-
membrane protein contributing to capsular polysaccharide 
formation, coexists with serotype K1 and has been identiﬁ  ed 
as the major virulence factor of K. pneumoniae (6). MagA-
positive (or serotype K1) K. pneumoniae is accordingly rec-
ognized as the main pathogen of pyogenic liver abscess (7,8). 
Nevertheless, how diabetes increases the risk for Klebsiella 
spp. liver abscess is still not clear. Further research is needed 
on whether pyogenic liver abscess is affected by immuno-
compromised conditions, such as malignancy, renal failure, 
postorgan transplantation, or HIV infection.
To clarify the epidemiology and pathogenesis of pyogen-
ic liver abscess, we used information gathered by the Taiwan 
National Health Insurance (NHI) program, which was initi-
ated in 1995 by the government to cover most Taiwanese citi-
zens. In 2005, 91.25% of healthcare providers were enrolled 
in the program and 99% of Taiwanese were insured (9). Con-
sequently, since 1995, the program has obtained comprehen-
sive health data on the population in Taiwan. In this study, we 
used NHI data to study the incidence and death rates caused 
by pyogenic liver abscess in Taiwan and to investigate factors 
modifying the manifestations of this disease.
Methods
Patients
We requested data on patients with pyogenic liver ab-
scess from the Taiwan NHI program. Cases were selected 
by using the following criteria: patients were hospitalized 
and reported before 2004, and the discharge diagnoses in-
cluded abscess of liver per the International Classiﬁ  cation 
of Diseases, 9th revision, Clinical Modication (ICD-9-
CM 572.0) but excluded amebic liver abscess (ICD-9-CM 
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006.3). Though we selected cases documented up to the 
end of 2004, the database could not provide information 
from patients who had not yet been discharged. Those ad-
mitted before December 31, 2004, but discharged during or 
after 2005 were therefore not included in our database. This 
exclusion results in the underestimation of case-patients 
admitted at the end of 2004. 
Data on 29,965 case-patients were collected. After ex-
cluding patients discharged before 1996 and those without 
clear records regarding age or sex, we enrolled 29,703 case-
patients in our study. Patient data were anonymous. Names 
of these patients were not included, and patient and health-
care provider identiﬁ  cation numbers were encrypted.
This primary set of data included the date of admission 
and discharge, age, sex, diagnoses (up to 5), procedures (up 
to 5), outcome at discharge (recovered or died), and the 
fees charged to patients. Laboratory data, including micro-
biologic data and medication, were not included. Any un-
derlying diseases were determined by the diagnoses listed 
in the medical records, which were coded by ICD-9-CM.
Because K. pneumoniae is the major pathogen of pri-
mary pyogenic liver abscess in Taiwan, it is expected to 
play an important role in the pathogenesis and prognosis 
of this disease. Unfortunately, the NHI database does not 
include microbiologic data. To compensate for this, we 
reviewed the records of patients in National Taiwan Uni-
versity Hospital (NTUH). This hospital is a public medical 
center in Taipei, functioning both as a primary care hospital 
and as a tertiary referral center (10). As the leading hos-
pital in Taiwan (10) with a 113-year history (11), NTUH 
serves patients and accepts referrals evenly distributed 
from every part of Taiwan. The hospital provides care for 
≈2,000 inpatients and 7,000 outpatients a day (11), which 
are ≈3.5% and 2%, respectively, of persons included in the 
NHI database (12). Therefore, the patients of NTUH are 
representative of all of the patients in Taiwan, without sub-
stantial bias but may be skewed slightly to the severe side. 
We selected case-patients from this hospital using the same 
criteria mentioned above, except that the discharge year 
was between January 1, 2000, and December 31, 2004; 
complete microbiologic data was preserved in the NTUH 
laboratory only after 2000. These patients were included 
in the NHI database anonymously. For case-patients from 
NTUH, we reviewed actual medical records and obtained 
microbiologic data from the hospital’s laboratory.
Statistical Analysis
Numerical data were compared by Student t test or 
paired t test. Categorical data were processed by χ2 test. 
Pearson correlation coefﬁ  cients and χ2 goodness-of-ﬁ  t test 
were used to estimate the trend of incidence and death over 
time. Unfortunately, incidence and death from different 
years could not be directly compared because the popula-
tion structure changed slightly over the study period. To 
correct the bias, we calculated age-standardized incidence 
and death rates. The correction was based on age-speciﬁ  c 
population data in 1996. Finally, risk factor analysis was 
conducted by using the binary logistic regression and curve 
estimation methods by SPSS version 11.0 for Macintosh 
(SPSS, Inc. Chicago, IL, USA).
Results
Demographic Data
A total of 29,703 case-patients from the NHI database 
were enrolled in our analysis (Table 1). Ages of these pa-
tients ranged from <1 through 106 years of age, with a me-
dian age of 61 years; a total of 9,904 (33.3%) had diabetes 
mellitus, 3,079 (10.4%) had cirrhosis of the liver, 4,350 
(14.6%) had cholelithiasis, and 4,115 (13.9%) had con-
comitant malignancy.
Average hospitalization was 17.33 days. The propor-
tions of patients who received abscess drainage and biliary 
procedures (endoscopic or surgical biliary drainage) were 
33.6% and 14.6%, respectively. The death rate was 10.9%.
Male patients dominated the sample population 
(18,326/29,703, 61.7%) and, on average, were 5 years 
younger than their female counterparts (57.58 ± 16.03 vs. 
62.13 ± 14.87 years, p<0.001). Besides the difference in 
age, more female patients had concomitant cholelithiasis 
(18.6% vs. 12.2%, p<0.001). Female patients also received 
biliary procedures more often (17.3% vs. 12.9%, p<0.001) 
than did male patients.
We then investigated the data over time. An average 
of 3,300 cases/year or 275 cases/month were reported. The 
number of reported cases increased from 2,400 in 1996 to 
3,991 in 2004 (Table 2), with a stable increase rate of 1.44 
more new cases per month (Figure 1); the decline in cases 
at the end of 2004 is possibly due to the incomplete recruit-
ment of cases as described in the Methods section.
The annual number of case-patients increased with age; 
peak incidence for women was seen in those 60–64 years 
of age and in men 65–69 years of age. A slight decline was 
noted in case-patients 55–59 years of age, a reﬂ  ection of 
decreased birth rates during World War II. Men <85 years 
of age had more liver abscess than women but the opposite 
was seen in women >85 years of age.
Incidence and Risk Factors
The gross incidence of pyogenic liver abscess from 
1996 through 2004 was 14.87 cases/100,000 population/
year (17.94 male cases/100,000 population and 11.65 fe-
male cases/100,000 population). The annual increase 
of incidence was 0.86 cases/100,000 population (r = 
0.98, p<0.001) (Figure 2, panel A). When we calculated 
age-standardized incidences, the increase rate was 0.51 
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cases/100,000 population/year (r = 0.92, p<0.001) (Figure 
2, panel B). The age of highest incidence in men was in 
those 80–84 years of age (86.71 cases/100,000 population); 
for women, the highest incidence was in those 85–89 years 
of age (79.80 cases/100,000 population).
Several factors were associated with the increased in-
cidence of liver abscess. Because incidence data from each 
year could not be merged directly, we chose the cases re-
ported in 2004 to evaluate the relative risk for each factor 
(Table 3). Diabetes mellitus and malignancy were asso-
ciated with a ≈10-fold increased risk, while renal disease 
and pneumonia tripled and quadrupled the incidence of 
liver abscess, respectively. We did not investigate the in-
teractions among these factors because it required detailed 
health records of each person in the Taiwan population, 
which would violate patient conﬁ  dentiality regulations.
Change in Death Rates
In contrast to increased incidence rates from 1996 
through 2004, the disease-speciﬁ   c death rate declined 
steadily from 12.33% in 1996 to 9.72% in 2004 while the 
number of deaths caused by pyogenic liver abscess in-
creased slightly over this same timeframe (Figure 2, panel 
B). The yearly change in the death rate was –0.31% (r = 
0.91, p<0.001) (Figure 3, panel A). When we calculated 
age-standardized death rates, the decrease was 0.38%/year 
(r = 0.94, p<0.001) (Figure 3, panel B). Death rates did not 
differ much between males and females (10.7% vs. 11.3%) 
(Table 1). Death rates increased slowly for men and women 
35–85 years of age and peaked for those 90–94 years of age 
(33.81%). Minor peaks were noted for adolescents 10–14 
years of age (19.35%) and for young men 20–24 years of 
age (12.36%), respectively.
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Table 1. Demographic data from National Health Insurance database, Taiwan, 1996–2004 
Item  Female  Male  Total  p value* 
Sex, no. (%)  11,377 (38.3)  18,326 (61.7)  29,703 (100)   
Age: range (median), y  0–106 (63.90)  0–101 (58.98)  0–106 (61.00)  <0.001† 
Age: mean (SD), y  62.13 (14.87)  57.58 (16.03)  59.32 (15.75)  <0.001‡ 
Hospitalization: mean (SD), d  18.00 (13.80)  16.91 (12.74)  17.33 (13.17)  <0.001‡ 
Diabetes mellitus, no. (%)  3,998 (35.1)  5,906 (32.2)  9,904 (33.3)  <0.001§ 
Cirrhosis, no. (%)  854 (7.5)  2,225 (12.1)  3,079 (10.4)  <0.001§ 
Renal disease, no. (%)  772 (6.8)  1,191 (6.5)  1,963 (6.6)  0.334§ 
Hypertension, no. (%)  1,491 (13.1)  1,866 (10.2)  3,357 (11.3)  <0.001§ 
Heart disease, no. (%)  826 (7.3)  1,118 (6.1)  1,944 (6.5)  <0.001§ 
Cerebrovascular accident, no. (%)  364 (3.2)  454 (2.5)  818 (2.8)  <0.001§ 
Cholelithiasis, no. (%)  2,121 (18.6)  2,229 (12.2)  4,350 (14.6)  <0.001§ 
Hepatobiliary malignancy, no. (%)  863 (7.6)  1,769 (9.7)  2,632 (8.9)  <0.001§ 
Other malignancy, no. (%)  546 (4.8)  937 (5.1)  1,483 (5.0)  0.227§ 
Pneumonia, no. (%)  675 (5.9)  1,273 (6.9)  1,948 (6.6)  0.001§ 
Urinary tract infection, no. (%)  923 (8.1)  697 (3.8)  1,620 (5.5)  <0.001§ 
Acute viral hepatitis, no. (%)  228 (2.0)  657 (3.6)  885 (3.0)  <0.001§ 
Peptic ulcer, no. (%)  985 (8.7)  1,623 (8.9)  2,608 (8.8)  0.557§ 
Abscess drainage no. (%)  3,886 (34.2)  6,082 (33.2)  9,968 (33.6)  0.082§ 
Biliary procedure no. (%)  1,967 (17.3)  2,361 (12.9)  4,328 (14.6)  <0.001§ 
Deaths, no. (%)  1,286 (11.3)  1,954 (10.7)  3,240 (10.9)  0.085§ 
*p<0.05 is considered statistically significant. 
†Mann-Whitney U test. 
‡Student t test. 
§Ȥ
2 test.  
Table 2. Incidence rates and deaths from pyogenic liver abscess, National Health Insurance database, Taiwan, 1996–2004* 
Case-patients with pyogenic liver abscess Deaths from pyogenic liver abscess
Year  Female Male  Total Female  Male  Total 
1996  945 (9.03)  1455 (13.15)  2400 (11.15)  112 (1.07)  184 (1.66)  296 (1.38) 
1997  1045 (9.88)  1562 (13.99)  2607 (11.99)  135 (1.28)  173 (1.55)  308 (1.42) 
1998  1130 (10.58)  1701 (15.13)  2831 (12.91)  151 (1.41)  189 (1.68)  340 (1.55) 
1999  1162 (10.78)  1936 (17.11)  3098 (14.02)  138 (1.28)  213 (1.88)  351 (1.59) 
2000  1300 (11.94)  2094 (18.38)  3394 (15.24)  147 (1.35)  201 (1.76)  348 (1.56) 
2001  1453 (13.25)  2218 (19.39)  3671 (16.38)  160 (1.46)  258 (2.25)  418 (1.87) 
2002  1406 (12.74)  2485 (21.64)  3891 (17.28)  151 (1.37)  259 (2.26)  410 (1.82) 
2003  1434 (12.93)  2386 (20.72)  3820 (16.90)  143 (1.29)  238 (2.07)  381 (1.69) 
2004  1502 (13.47)  2489 (21.57)  3991 (17.59)  149 (1.34)  239 (2.07)  388 (1.71) 
p value†  <0.001  <0.001  <0.001  0.224  <0.001  <0.001 
*Data are presented as number (rate per 100,000 population). 
†Ȥ
2 goodness-of-fit test. p<0.05 is considered statistically significant. Pyogenic Liver Abscess, Taiwan
We tested case-patients with binary logistic regression 
to identify the factors contributing to increased death rates 
(Table 4). Multivariate analysis showed an increased risk 
of 1.7%/year of age. Renal disease and malignancy were 
respectively associated with a 2.5- and a 2-fold increased 
risk, followed by pneumonia (1.5-fold) and heart disease 
(1.3-fold). Some underlying diseases were associated with 
a lower risk for death, including diabetes (0.85-fold), pep-
tic ulcer (0.75- fold), urinary tract infection (0.74-fold), 
hypertension (0.44-fold), and cholelithiasis (0.69-fold). 
Therapeutic procedures were also related to the lower risk 
of death (abscess drainage 0.57-fold, biliary drainage 0.73-
fold), compatible with our expectations.
K. pneumoniae and Pyogenic Liver Abscess at NTUH
To compensate for the deﬁ   ciency of microbiologic 
data in the NHI database, we reviewed the medical records 
of case-patients with primary pyogenic liver abscess admit-
ted to NTUH from 2000 through 2004. In total, 506 case-
patients were enrolled, ≈3.70% of all case-patients in Tai-
wan (13,672) during the same period. This ratio is similar 
to the general NTUH: Taiwan inpatient ratio (3.50%) (12), 
suggesting that liver-abscess cases in NTUH are probably 
a microcosm for the liver-abscess patients in all of Taiwan. 
Demographic data are shown in Table 5. Compared with 
the NHI database, case-patients in NTUH had longer hos-
pitalization periods and higher frequencies of heart disease 
and malignancy, implying severe underlying conditions. 
However, the ratios of sepsis, meningitis, endophthalmitis, 
and pneumonia were similar between NTUH and Taiwan 
data, so the severity of primary liver abscess in NTUH pa-
tients and Taiwan as a whole were equal. Besides, NTUH 
case-patients were associated with higher rates of abscess 
drainage and lower death rates, indicating that the quality 
of medical care for those patients is probably better than the 
average level of medical care provided in Taiwan.
Among the 506 cases, 358 had positive culture results 
(Table 6), and 286 (79.9%) of 358 case-patients showed K. 
pneumoniae infection. Patients with Klebsiella spp. infec-
tion had a lower death rate (2.4% vs. 11.1%; p = 0.004), less 
mixed bacterial infection (4.5% vs. 26.4%; p<0.001), and 
less underlying malignancy (5.2% vs. 20.8%; p<0.001). Of 
case-patients with Klebsiella spp. liver abscess, 35% were 
associated with diabetes mellitus. The prevalence of dia-
betes in case-patients with other micromicrobial infections 
was 18.1% (p = 0.007). Binary logistic regression analysis 
showed that Klebsiella spp. infection was associated with 
decreased death rates (relative risk 0.20, p = 0.003); the 
role of diabetes was neutral (relative risk 1.09, p = 0.88) 
(Table 7). Therefore, the low death rates in case-patients 
with diabetes who also had liver abscess were probably at-
tributed to Klebsiella spp. infection.
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Figure 1. Number of new reported cases of pyogenic liver abscess 
recorded monthly in the National Health Insurance database, 
Taiwan, January 1996 through December 2004.
Figure 2. Incidence of pyogenic liver abscess in Taiwan, showing 
a steady increase from 1996 to 2004. The incidence is expressed 
as the number of new cases reported from the population (the 
National Health Insurance database) per year. A) The linear 
increase of the primary incidence data (raw incidence: cases/year × 
1/100,000) with the year can be described by the formula Incidence 
× 1/100,000 = 0.860 × year – 1704.66 (r = 0.978, p<0.001). B) The 
linear increase of the standardized incidence data (raw incidence 
normalized according to the age distribution of the population) with 
the year can be described by the formula Incidence × 1/100,000 = 
0.512 × year – 1010.68 (r = 0.923, p<0.001). r, Pearson correlation 
coefﬁ  cient. p<0.05 is considered statistically signiﬁ  cant.RESEARCH
Discussion
We present a nationwide population-based report of 
pyogenic liver abscess in Taiwan. Taiwan started the NHI 
program in 1995, with a coverage rate of ≈99% of its popu-
lation. By providing national healthcare, the system col-
lected medical records from virtually every person seeking 
medical help in Taiwan so many nationwide surveys were 
automatically completed. The database, therefore, reﬂ  ects a 
complete and unbiased picture of general health conditions 
in Taiwan.
Our data suggests Taiwan is endemic for pyogenic 
liver abscess. This disease had been considered rare in the 
past; previous reports showed an annual incidence rate of 
2.3/100,000 (13) and 1.0/100,000 (14) in Canada and Den-
mark, respectively. In our report, however, the incidence 
rate was 10× higher (11.99/100,000 in 1996 and up to 
17.59/100,000 in 2004). Such high incidence rates and rapid 
increase indicate the true growth of this disease because the 
data could not be explained solely by the change in popula-
tion structure or by improved detection capacity of medical 
professionals. First, the diagnostic tools and methods for 
pyogenic liver abscess did not remarkably change during 
our study. Furthermore, the incidence did not explode but 
increased steadily over time. Thus, the increase is unlikely 
to have been caused by improved diagnostic sensitivity. 
Second, to eliminate bias induced by the change in popu-
lation structure over time, we calculated age-standardized 
incidence. The increased incidence remains signiﬁ  cant af-
ter correction (Figure 2, panels A, B). Hence, endemic pyo-
genic liver abscess possibly existed long before these data 
were ﬁ  rst collected in Taiwan, even though the situation 
has recently become much worse. During the study period, 
magA-positive K. pneumoniae was identiﬁ  ed as the major 
cause of pyogenic liver abscess in Taiwan (6,15). Although 
culture data were lacking in the NHI database, 80% of 
NTUH case-patients had positive culture data that showed 
Klebsiella spp. A recent nationwide report from South Ko-
rea also showed that the proportion of K. pneumoniae infec-
tion increased dramatically in that country over time from 
≈0% in 1955–1969 up to 78.2% during 2004–2005 (8). We 
can therefore infer that the high incidence of pyogenic liver 
abscess in Taiwan is related to Klebsiella spp. infection.
In contrast to the rise of incidence over time, death 
rates from pyogenic liver abscess decreased. In our analy-
sis, the death rate from pyogenic liver abscess in Taiwan 
was 10.9% during 1996–2004 (Table 1) while the inhospital 
death rate was 6.1% (Table 5). These rates are much lower 
than those in earlier reports, 25% (16) to 50% (14), but 
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Table 3. Factors associated with increased incidence in pyogenic 
liver abscess based on cases reported in the National Health 
Insurance database, Taiwan, 2004* 
Factor 
Incidence
with factor 
Incidence
without factor 
Relative risk 
(95% CI) 
Sex (M)  21,565  13,474  1.601
(1.501–1.707) 
Acute viral 
hepatitis 
50,798  17,090  2.973
(2.511–3.466) 
Diabetes mellitus  111,998  12,322  9.098
(8.520–9.716) 
Malignancy  162,610  15,176  10.731
(9.840–11.702) 
Hypertension  23,989  16,772  1.430
(1.313–1.559) 
CVA  22,756  17,471  1.303
(1.083–1.567) 
Pneumonia  77,048  16,541  4.661
(4.145–5.240) 
Renal disease  62,795  16,878  3.722
(3.250–4.263) 
Heart disease  19,494  17,468  1.116
(0.986–1.264) 
*Incidence is expressed as cases/100,000 population. CI, confidence 
interval; CVA, cerebrovascular accident. 
Figure 3. Deaths from pyogenic liver abscess in Taiwan, showing a 
steady decrease from 1996 to 2004. Mortality rate is expressed as 
the number of deaths reported from pyogenic liver abscess cases 
per year. A) The linear decrease of the primary mortality data (raw 
mortality: deaths/case/year × 1/100) with the year can be described 
with this formula: Mortality × 1/100 = 0.314 × year + 639.58 (r = 
0.910, p<0.001). B) The linear decrease of the standardized 
mortality data (raw mortality normalized according to the age 
distribution of the population) with the year can be described with 
this formula: Mortality × 1/100 = 0.383 × year + 776.59 (r = 0.944, 
p<0.001). r, Pearson correlation coefﬁ  cient. p<0.05 is considered 
statistically signiﬁ  cant.Pyogenic Liver Abscess, Taiwan
are consistent with those in more recent reports, in which 
population-based death rates were ≈10% (13,14) while in-
hospital death rates ranged from 6%–8% (15,17,18). This 
decrease might be multifactorial. 
First, the decrease in death rates might be the result of 
the dramatic increase of case-patients with pyogenic liver 
abscess. In a previous report, Jepsen et al. suggested that the 
dramatic decrease in death rates in Denmark between 1977 
and 2002 resulted from improved diagnostic tools (14). 
This reason might also apply in Taiwan because the liver 
abscess–related death rate in the general population actu-
ally increased from 1.38/100,000 in 1996 to 1.80/100,000 
in 2004. However, the increase was not steady, with a peak 
of 1.94/100,000 in 2001 followed by a decrease, indicating 
a true decrease of disease-speciﬁ  c deaths. Thus, diagnostic 
sensitivity could not explain the whole condition. 
Second, the advance of medical care might have con-
tributed to the decrease in mortality rates. Because abscess 
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Table 4. Binary logistic regression analysis showing factors associated with death from pyogenic liver abscess, Taiwan, 1996–2004* 
Univariate analysis  Multivariate analysis 
Factor  Odds ratio p value†  95% CI Odds ratio p value†  95% CI
Age, y  1.018 <0.001 1.015–1.020 1.017 <0.001 1.015–1.020
Sex (M)  0.937 0.085 0.869–1.009 0.930 0.067 0.861–1.005
Diabetes mellitus   0.813 <0.001 0.750–0.880 0.850 <0.001 0.782–0.925
Abscess drainage  0.541 <0.001 0.497–0.590 0.571 <0.001 0.523–0.624
Biliary procedure  0.635 <0.001 0.564–0.715 0.728 <0.001 0.640–0.828
Peptic ulcer  0.778 <0.001 0.676–0.895 0.751 <0.001 0.651–0.867
Urinary tract infection   0.851 0.063 0.718–1.009 0.735 0.001 0.617–0.875
Cirrhosis 1.027 0.663 0.912–1.156  – –  – 
Renal disease  2.599 <0.001 2.322–2.909 2.452 <0.001 2.181–2.756
Hypertension   0.480 <0.001 0.414–0.557 0.435 <0.001 0.374–0.506
Cerebrovascular accident   1.405 0.001 1.153–1.713 1.219 0.058 0.993–1.497
Cholelithiasis 0.599 <0.001 0.530–0.676 0.693 <0.001 0.608–0.790
Hepatobiliary malignancy  1.745 <0.001 1.564–1.947 1.850 <0.001 1.646–2.080
Other malignancy  2.151 <0.001 1.883–2.456 2.136 <0.001 1.859–2.454
Pneumonia 1.770 <0.001 1.563–2.003 1.516 <0.001 1.333–1.723
Acute viral hepatitis  0.481 <0.001 0.361–0.642 0.431 <0.001 0.321–0.578
Heart disease  1.384 <0.001 1.212–1.581 1.254 0.001 1.092–1.440
*CI, confidence interval.  
†p<0.05 is considered statistically significant.  
Table 5. Demographic data on patients with primary pyogenic liver abscess from NTUH and NHI databases, Taiwan, 2000–2004* 
Item  NHI database  NTUH  p value† 
Total no. case-patients  13,672  506 (3.70) 
Age, y, range (median)  0–100 (59.95)  0–90 (57.50) 
Age, y, mean (SD)  58.31 (16.37)  55.92 (16.93)  0.001 
Hospitalization, mean (SD)  17.32 (12.80)  30.13 (34.08)  <0.001 
M/F, no. (%)  8,652/5,020 (63.3/36.7)  329/177 (65.0/35.0)  0.426 
Diabetes mellitus, no. (%)  5,428 (39.7)  140 (27.7)  <0.001 
Cirrhosis, no. (%)  1,153 (8.4)  19 (3.8)  <0.001 
Renal disease, no. (%)  1,113 (8.1)  47 (9.3)  0.355 
Hypertension, no. (%)  1,947 (14.2)  88 (17.4)  0.047 
Heart disease, no. (%)  1,038 (7.6)  53 (10.5)  0.017 
Cerebrovascular accident, no. (%)  461 (3.4)  17 (3.4)  0.988 
Other malignancy, no. (%)  930 (6.8)  77 (15.2)  <0.001 
Sepsis, no. (%) 3,252 (23.8) 137 (27.1) 0.089
Meningitis, no. (%) 155 (1.1) 6 (1.2) 1.000
Endophthalmitis, no. (%) 226 (1.7) 10 (2.0) 0.593
Pneumonia, no. (%)  1,141 (8.3)  54 (10.7)  0.064 
Urinary tract infection, no. (%)  916 (6.7)  20 (4.0)  0.015 
Acute viral hepatitis, no. (%)  400 (2.9)  10 (2.0)  0.211 
Peptic ulcer, no. (%)  1,161 (8.5)  20 (4.0)  <0.001 
Abscess drainage, no. (%)  4,795 (35.1)  292 (57.7)  <0.001 
Biliary procedure, no. (%)  790 (5.8)  15 (3.0)  0.007 
Deaths, no. (%)  1,410 (10.3)  31 (6.1)  0.002 
*Data expressions and statistical methods in this table are the same as in Table 1. NTUH, National Taiwan University Hospital; NHI, National Health 
Insurance.  
†p<0.05 is considered statistically significant. RESEARCH
drainage was reported to improve the outcome (2,15,19) 
and Klebsiella spp. was associated with a relatively be-
nign course under aggressive medical care (5,20), we hy-
pothesized that the decrease in death rates was due to the 
increase of Klebsiella spp. infection and the increase of 
abscess drainage. To test this hypothesis, we calculated 
the trends of death-related factors over time in the NHI 
database. As indicated in Table 8, the decrease in death 
rates was chronologically compatible with the increase of 
abscess drainage (+1.38% per year, r = 0.88, p = 0.002). 
Although the database did not include culture data, the 
annual increase of diabetes (+0.69%, r = 0.86, p = 0.003) 
and pneumonia (+0.28%, r = 0.90, p = 0.001) suggested 
the concomitant annual increase of Klebsiella spp. infec-
tion. Therefore, the signiﬁ  cant decrease of liver abscess-
related deaths in recent years is caused by a microbiologic 
shift (more Klebsiella spp. infections) and better medical 
care (more abscess drainage).
Our study suggests that both underlying renal disease 
and malignancy increased the incidence and mortality rates 
of pyogenic liver abscess. A previous survey in patients 
with end-stage renal disease showed the in-hospital preva-
lence of liver abscess to be 130.59/100,000 and the death 
rate to be 33.30% (21). Patients died of septic shock despite 
aggressive management in 50% of these cases. In our data, 
renal disease triples the incidence of pyogenic liver abscess 
and doubles the death rates, compatible with the previous 
report. Similarly, underlying malignancy had been well rec-
ognized as an important aggravating factor (13,22) of liver 
abscess. Our data also showed 10-fold and 2-fold increases 
in the incidence and mortality rates of pyogenic liver ab-
scess. In addition to the fact that tumors from the hepatobil-
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Table 6. Klebsiella spp. liver abscess compared with other primary pyogenic liver abscess, NTUH, Taiwan, 1996–2004* 
Item  Klebsiella spp.  Non-Klebsiella spp.  p value† 
Total no.  286  72   
Male gender, no. (%)   191 (66.8)  45 (62.5)  0.490 
Deaths, no. (%)  7 (2.4)  8 (11.1)  0.004 
Abscess drainage, no. (%)  204 (71.3)  49 (68.1)  0.664 
Biliary procedure, no. (%)  2 (0.7)  9 (12.5)  <0.001 
Mixed infection, no. (%)  13 (4.5)  19 (26.4)  <0.001 
Diabetes mellitus, no. (%)  100 (35.0)  13 (18.1)  0.007 
Peptic ulcer, no. (%)  10 (3.5)  7 (9.7)  0.055 
Urinary tract infectio, no. (%)  14 (4.9)  2 (2.8)  0.749 
Renal disease, no. (%)  25 (8.7)  6 (8.3)  1.000 
Hypertension, no. (%)  55 (19.2)  14 (19.4)  1.000 
Heart disease, no. (%)  28 (9.8)  9 (12.5)  0.517 
Cerebrovascular accident, no. (%)  7 (2.4)  3 (4.2)  0.427 
Malignancy, no. (%)  15 (5.2)  15 (20.8)  <0.001 
Cirrhosis, no. (%)  5 (1.7)  2 (2.8)  0.632 
Pneumonia, no. (%)  35 (12.2)  6 (8.3)  0.414 
Viral hepatitis, no. (%)  4 (1.4)  1 (1.4)  1.000 
Meningitis, no. (%)  3 (1.0)  0 (0.0)  0.613 
Endophthalmitis  9 (3.1)  0 (0.0)  0.214 
Age, y, mean (SD)  57.39 (15.52)  55.25 (19.26)  0.384 
No. hospitalizations, mean (SD)  26.12 (16.36)  43.06 (69.64)  0.044 
*NTUH, National Taiwan University Hospital. The Ȥ
2 test and Student t test were used for statistical analyses.  
†p<0.05 is considered statistically significant. 
Table 7. Factors modifying the death rates from primary pyogenic liver abscess analyzed by binary logistic regression, NTUH, Taiwan, 
2000–2004*
Univariate analysis  Multivariate analysis 
Factor  Odds ratio p value†  95% CI  Odds ratio  p value†  95% CI 
Age 1.034 0.074 0.997–1.073 –– –
Gender  0.436 0.117 0.154–1.231 –– –
Klebsiella 0.201 0.003 0.070–0.574 0.223 0.009 0.072–0.690
Diabetes mellitus   1.088 0.880 0.363–3.260 –– –
Renal disease  4.256 0.019 1.269–14.271  6.172 0.006 1.665–22.884 
Heart disease  1.354 0.698 0.293–6.247 –– –
Malignancy  4.433 0.016 1.319–14.900  2.922 0.119 0.759–11.254 
Cirrhosis 4.012 0.212 0.452–35.613  –– –
Abscess drainage  0.345 0.045 0.122–0.977 0.351 0.063 0.116–1.060
Hospitalization days  1.002 0.793 0.990–1.013 –– –
*NTUH, National Taiwan University Hospital; CI, confidence interval. 
†p<0.05 is considered statistically significant. Pyogenic Liver Abscess, Taiwan
iary region might mimic abscesses (23–25), tumors in other 
regions were also associated with poor prognoses (26,27), 
conﬁ  rming malignancy itself as an independent aggravat-
ing factor. Because the prevalence of both renal disease 
and malignancy has increased in recent years, the threat of 
pyogenic liver abscess in those patients is becoming more 
important, worthy of our special notice.
In contrast to renal disease and malignancy, the role 
of diabetes in mortality rates is controversial. Some reports 
suggested its association with a more aggressive clinical 
course (18,28) while others merely conﬁ  rmed its coexis-
tence with pyogenic liver abscess (15,19,22). In our analy-
sis of the NHI database, diabetes caused a 9-fold increase 
of incidence but paradoxically decreased death rates. Fur-
ther analysis in NTUH case-patients showed that such a 
decrease was attributed to the high proportion of Klebsiella 
spp. infection and that diabetes played no signiﬁ  cant role 
in prognoses. This result is compatible with a report from 
a recent population-based case-control study in Denmark 
which stated that diabetes modiﬁ  ed the risk but not the 
prognosis of pyogenic liver abscess (29). Since diabetes 
compromises host immune systems, its pivotal role in the 
risk for abscess but minimal role in abscess-related death, 
indicates a complicated interaction between the pathogens 
and the immune system of hosts. More in-depth research in 
this ﬁ  eld is necessary.
The NHI database, although almost complete, is lim-
ited in 3 aspects. First, it is deﬁ  cient in microbiologic data. 
Because the microbiologic data from NTUH is hospital-
based, data might not accurately reﬂ  ect the condition in the 
general population. Second, because it enables only 5 diag-
noses for each case, coding of diagnoses might be biased if 
the speciﬁ  c case is complicated with >5 underlying diseas-
es. For this reason, some minor conditions, such as peptic 
ulcer, urinary tract infection, and hypertension, paradoxi-
cally decreased death rates in our data. Third, in contrast to 
the comprehensive data of pyogenic liver abscess, detailed 
health data for each person in the population are not avail-
able. We are therefore unable to estimate the interaction 
among the risk factors of pyogenic liver abscess in the pop-
ulation (Table 3). Nevertheless, this study still provides a 
clear picture of pyogenic liver abscess in Taiwan. The rapid 
and steady increase of cases with pyogenic liver abscess in 
Taiwan should be noted (Table 2). Although the prognosis 
of liver abscess patients has improved over time (Figure 3), 
pyogenic liver abscess-related death in the population con-
tinues to increase (Table 2). Furthermore, complex interac-
tions between pyogenic liver abscess, diabetes, renal dis-
ease, and malignancy are shown to worsen this condition. 
Further collaboration among clinical medical practitioners, 
public health workers, and research scientists is mandatory 
to ﬁ  ght against such a challenge in the future. 
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Table 8. Chronologic changes of factors associated with pyogenic liver abscess, NHI database, Taiwan, 1996–2004* 
Year (no. cases)  
Abscess
drainage,
no. (%) 
Biliary 
procedure,
no. (%) 
Renal
disease,
no. (%) 
Diabetes
mellitus,
no. (%) 
Hepatobiliary 
malignancy, 
no. (%) 
Other
malignancy, 
no. (%) 
Pneumonia,
no. (%) 
Heart
disease,
no. (%) 
Deaths,
no. (%) 
1996 (2,400)  589
(24.5)
316
(13.2)
123
(5.1)
696
(29)
149
(6.2)
81
(3.4)
132
(5.5)
137
(5.7)
296
(12.3)
1997 (2,607)  729
(28)
389
(14.9)
156
(6)
819
(31.4)
210
(8.1)
106
(4.1)
155
(5.9)
154
(5.9)
308
(11.8)
1998 (1,831)  932
(32.9)
473
(16.7)
161
(5.7)
911
(32.2)
276
(9.7)
124
(4.4)
168
(5.9)
186
(6.6)
340
(12)
1999 (3,098)  1,055
(34.1)
480
(15.5)
198
(6.4)
1,005
(32.4)
302
(9.7)
137
(4.4)
179
(5.8)
194
(6.3)
351
(11.3)
2000 (3,394)  1,190
(35.1)
484
(14.3)
258
(7.6)
1,139
(33.6)
292
(8.6)
171
(5)
193
(5.7)
198
(5.8)
348
(10.3)
2001 (3,671)  1,233
(33.6)
515
(14)
286
(7.8)
1,241
(33.8)
340
(9.3)
203
(5.5)
246
(6.7)
254
(6.9)
418
(11.4)
2002 (3,891)  1,355
(34.8)
604
(15.5)
279
(7.2)
1,339
(34.4)
372
(9.6)
206
(5.3)
290
(7.5)
264
(6.8)
410
(10.5)
2003 (3,820)  1,387
(36.3)
519
(13.6)
281
(7.4)
1,411
(36.9)
347
(9.1)
195
(5.1)
282
(7.4)
290
(7.6)
381
(10.0)
2004 (3,991)  1,498
(37.5)
548
(13.7)
221
(5.5)
1,343
(33.7)
344
(8.6)
260
(6.5)
303
(7.6)
267
(6.7)
388
(9.7)
Change per y, %  +1.38 (–0.10) +0.17 +0.69 +0.20 +0.31 +0.28 +0.17 (–0.31)
r 0.88 –0.23 0.46 0.86 0.49 0.93 0.90 0.75 –0.91
p value†  0.002 0.547 0.208 0.003 0.179 <0.001 0.001 0.020 0.001
*NHI, National Health Insurance; r, Pearson correlation coefficient.   
†p<0.05 is considered statistically significant. RESEARCH
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